PAR
Click for more information
0.85% 29.8¢ paradigm biopharmaceuticals limited..

Ann: PAR Reports Successful Primary Endpoint in Phase 2 Trial, page-42

  1. Denial
    9,785 Posts.
    lightbulb Created with Sketch. 1235
    clock Created with Sketch.
    04/10/22
    12:53
    Post #: 64017233
    Do we need to "hope" or rather can the dosage be revised following consultation with FDA?

    I note the Marco suggested there will be an "update PARA_OA_002 Stage 1 dose selection 1H CY2023" which as also disclosed on slide 13.
    PAR Price at posting: $1.50 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

DMP Domino's locks in biggest faller status on Thursday as it closes stores in Asia, Europe
right-arrow Created with Sketch.
FG1 Flynn Gold flags mid-grade drill hits and always eye-catching rock chips
right-arrow Created with Sketch.
AMI First stope ore could be pushed back to Q2 FY25 due to flood-like event: Aurelia
right-arrow Created with Sketch.
NEWS Talking Australia's very competitive property landscape: Realty Talks
right-arrow Created with Sketch.
AUN Aurumin reports high-grade iron ore rock chips at Central Sandstone, WA
right-arrow Created with Sketch.
FMG Andrew Forrest was seemingly possessed by the spirit of hydrogen – now he's cut 700 jobs and canned FFI
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
29.8¢ 		Change
0.003(0.85%) 		Mkt cap ! $103.1M
Open High Low Value Volume
30.0¢ 30.0¢ 29.5¢ $13.61K 45.43K

Buyers (Bids)

No. Vol. Price($)
6 74204 29.5¢
 

Sellers (Offers)

Price($) Vol. No.
30.0¢ 15115 6
View Market Depth
Last trade - 13.57pm 22/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.